FDG-PET in infectious lesions: The detection and assessment of lesion activity

Sasaki M, Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Fukumura T, et al. Ringlike uptake of [18F]FDG in brain abscess: A PET study.J Comp Assist Tomogr 14: 486–487, 1990.

Hanson MW, Glantz MI, Hoffman JM, Friedman AH, Burger PC, Schold SC, et al. FDG-PET in the selection of brain lesions for biopsy.J Comp Assist Tomogr 15: 796–801, 1991.

Meyer MA, Frey KA, Schwaiger M. Discordance between F-18 fluorodeoxyglucose uptake and contrast enhancement in abrain abscess.Clin NuclMed 18: 682–684, 1993.

Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, et al. Differential diagnosis of lung tumor with positron emission tomography: A prospective study.J Nucl Med 31: 1927–1933, 1990.

Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation.Radiology 191: 371–377, 1994.

Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules.Chest 104: 997–1002, 1993.

Patz EF Jr, Lowe VL, Hoffman JM, Paine SS, Burrowes S, Coleman RE, et al. Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxy glucose PET scanning.Radiology 188: 487–490, 1993.

Strauss LG, Conti PS. The application of PET in clinical oncology.J Nucl Med 32: 623–648, 1991.

Patz EF Jr, Lowe VL, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: Detection with PET and 2-[F-18]-2-deoxy-D-glucose.Radiology 191: 379–382, 1994.

Brudin LH, Valind S-O, Rhodes CG, Pantin CF, Sweatman M, Jones T, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography.EurJ Nucl Med 21: 297–305, 1994.

Tahara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Gunasekera RD, et al. High [F-18]-fluorodeoxy-glucose uptake in abdominal abscesses: A PET study.J Comp Assist Tomogr 13: 829–831, 1989.

Okazumi S, Enomoto K, Fukunaga T, Kikuchi T, Asano T, Isono K, et al. Evaluation of the cases of benign disease with high accumulation on the examination of F-18 fluorodeoxyglucose PET.KAKU IGAKU (Jpn J Nucl Med) 30: 1439–1443, 1993 (in Japanese).

Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy.J Nucl Med 32: 1485–1490, 1991.

Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, et al. Assessment of response to cancer therapy using Fluorine-18-fluorodeoxyglucose and positron emission tomography.J Nucl Med 32: 1655–1660, 1991.

West J, Morton DJ, Esmann V, Stjernholm RL. Carbohydrate metabolism in leukocytes. VIII. Metabolic activities of the macrophage.Archive Biochem Biophys 124: 85–90, 1968.

Borregaard NB, Herlin T. Energy metabolism of human neutrophils during phagocytosis.J Clin Invest 70: 550–557, 1982.

Weisdorf DJ, Craddock PR, Jacob HS. Glycogenolysis versus glucose transport in human granulocytes: Differential activation in phagocytosis and chemotaxis.Blood 60: 888–893, 1982.

Daley JM, Shearer JD, Mastrofrancesco B, Caldwell MD. Glucose metabolism in injured tissue: A longitudinal study.Surgery 107: 187–192, 1990.

Anderson RL, Wood WA. Carbohydrate metabolism in microorganisms.Ann Rev Microbiol 23: 539–578, 1969.

Tischler ME, Fagan JM. Response to trauma of protein, amino acid, and carbohydrate metabolism in injured and uninjured rat skeletal muscles.Metabolism 32: 853–868, 1983.

Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of Fluorine-18-fiuorodeoxy-glucosein vivo: High accumulation in macrophages and granulation tissues studies by microautoradiography.J Nucl Med 33: 1972–1980, 1992.

Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection.J Nucl Med 21: 670–675, 1980.

Marchesi VT. Inflammation and healing.In Anderson’s Pathology, Kissane JM (ed.), 8th ed., Mosby, pp. 22–60, 1985.

Staab EV, McCartney WH. Role of Gallium 67 in inflammatory Disease.Sem Nucl Med 8: 219–234, 1978.

Hoffer P. Gallium: Mechanisms.J Nucl Med 21: 282–285, 1980.

Sfakianakis GN, Al-Shikh W, Heal A, Rodman G, Zeppa R, Serafini A. Comparisons of scintigraphy with In- 111 leukocytes and Ga-67 in the diagnosis of occult sepsis.J Nucl Med 23: 618–626, 1982.

Goodwin DA. Clinical use of In-111 leukocyte imaging.Clin Nucl Med 8: 36–38, 1983.

Kipper MS, Williams RJ. Indium-111 white blood cell imaging.Clin Nucl Med 8: 449–455, 1983.

Datz FL, Thome DA. Effect of chronicity of infection on the sensitivity of the In-111-labeled leukocyte scan.AJR 147: 809–812, 1986.

Froelich JW, Swanson D. Imaging of inflammatory processes with labeled cells.Sem Nucl Med 14: 128–140, 1984.

Kuweit T, Ganslandt T, Jansen P, et al. Influence of size of regions of interest on PET evaluation of caudate glucose consumption.J Comput Assist Tomogr 16: 789–794, 1992.

Akashi Y, Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Fukumura T, et al. The partial volume effect correction for pulmonary mass lesions using a68Ga/68Ge transmission scan in PET study.KAKU IGAKU (Jpn J Nucl Med) 31: 1511–1517, 1994 (in Japanese).

Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with Fluorine-18 fluorodeoxyglucose.J Nucl Med 29: 1521–1525, 1988